During the COVID-19 pandemic, Xlear, a health products company, promoted its saline nasal spray as a means to prevent virus entry into the nasal cavity, citing scientific studies. However, in 2021, the FTC sued Xlear over allegedly unsupported health claims and misleading representation of scientific research. Despite the Justice Department seeking to dismiss the case, Xlear is now suing the FTC to limit the agency’s power to regulate health claims. This dispute emerges amid evolving governmental policies on scientific standards for health-related advertising.
Back
